Voyager Therapeutics VYGR
NASDAQ VYGR
$2.69 +0.05 (+2.08%)
As of: Sep 30, 2026 · 1:37 PM EDT

Voyager Therapeutics, Inc. (VYGR) Operating Income (2014 - 2026)

Updated

Voyager Therapeutics (VYGR) posted Operating Income of -$26.39 million for Q2 2026, compared with -$36.63 million a year earlier.

Analysis

Voyager Therapeutics, Inc. (VYGR) Operating Income (2014 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Income at Voyager Therapeutics was -$117.19 million; for FY2025, it was -$131.84 million.

  • In prior years, Voyager Therapeutics' Operating Income was -$83.29 million in FY2024, $122.01 million in FY2023, -$50.84 million in FY2022 and -$73.62 million in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Operating Income since Q3 2024.
  • According to Business Quant data, Operating Income for the three prior quarters was -$30.27 million (Q1 2026), -$29.93 million (Q4 2025) and -$30.59 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -26.39 Mn
Mar 31, 2026 -30.27 Mn
Dec 31, 2025 -29.93 Mn
Sep 30, 2025 -30.59 Mn
Jun 30, 2025 -36.63 Mn
Mar 31, 2025 -34.69 Mn
Dec 31, 2024 -38.30 Mn
Sep 30, 2024 -13.78 Mn
Jun 30, 2024 -15.03 Mn
Mar 31, 2024 -16.18 Mn
Dec 31, 2023 54.06 Mn
Sep 30, 2023 -29.51 Mn
Jun 30, 2023 -25.43 Mn
Mar 31, 2023 122.88 Mn
Dec 31, 2022 -24.56 Mn
Sep 30, 2022 14.44 Mn
Jun 30, 2022 -19.37 Mn
Mar 31, 2022 -21.35 Mn
Dec 31, 2021 5.70 Mn
Sep 30, 2021 -25.15 Mn
API Access

Voyager Therapeutics, Inc. Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=VYGR&period=max&api_key=YOUR_API_KEY